China Taiping Insurance Holdings Company Limited (HKG:0966)
12.02
-0.08 (-0.66%)
Mar 28, 2025, 4:08 PM HKT
HKG:0966 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Premiums & Annuity Revenue | 111,268 | 107,489 | 108,906 | 250,496 | 217,932 | Upgrade
|
Total Interest & Dividend Income | -53,216 | -26,389 | -11,767 | 44,294 | 36,774 | Upgrade
|
Gain (Loss) on Sale of Investments | 57,226 | 24,786 | 4,698 | 13,992 | 10,482 | Upgrade
|
Other Revenue | 5,725 | 6,470 | 6,368 | 7,331 | 5,956 | Upgrade
|
Total Revenue | 121,003 | 112,356 | 108,206 | 316,112 | 271,143 | Upgrade
|
Revenue Growth (YoY) | 7.70% | 3.84% | -65.77% | 16.59% | 10.47% | Upgrade
|
Policy Benefits | 89,244 | 88,958 | 90,956 | 244,646 | 197,691 | Upgrade
|
Policy Acquisition & Underwriting Costs | - | - | - | 24,107 | 21,146 | Upgrade
|
Selling, General & Administrative | - | - | - | 34,419 | 34,250 | Upgrade
|
Other Operating Expenses | 6,394 | 6,784 | 7,172 | 526.74 | 623.89 | Upgrade
|
Total Operating Expenses | 95,638 | 95,742 | 98,128 | 303,698 | 253,711 | Upgrade
|
Operating Income | 25,365 | 16,614 | 10,078 | 12,413 | 17,433 | Upgrade
|
Interest Expense | -3,457 | -3,764 | -3,123 | -2,688 | -2,667 | Upgrade
|
Earnings From Equity Investments | 2,665 | - | - | 609.43 | -1,571 | Upgrade
|
Currency Exchange Gain (Loss) | -943.12 | -113.85 | -398.07 | 583.23 | 74.08 | Upgrade
|
Other Non Operating Income (Expenses) | -645.8 | -258.14 | -72.3 | - | - | Upgrade
|
EBT Excluding Unusual Items | 22,983 | 12,478 | 6,484 | 10,919 | 13,268 | Upgrade
|
Impairment of Goodwill | - | -364.87 | - | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -46.9 | -3.62 | 1.75 | -4.69 | -3.51 | Upgrade
|
Asset Writedown | -808.66 | -451.33 | -371.73 | - | - | Upgrade
|
Pretax Income | 22,128 | 11,658 | 6,114 | 10,914 | 13,265 | Upgrade
|
Income Tax Expense | 9,330 | 1,381 | -2,243 | -38.54 | 2,808 | Upgrade
|
Earnings From Continuing Ops. | 12,798 | 10,277 | 8,357 | 10,952 | 10,457 | Upgrade
|
Minority Interest in Earnings | -4,366 | -4,087 | -4,060 | -3,439 | -3,908 | Upgrade
|
Net Income | 8,432 | 6,190 | 4,297 | 7,514 | 6,549 | Upgrade
|
Preferred Dividends & Other Adjustments | 999.18 | 815.82 | - | - | - | Upgrade
|
Net Income to Common | 7,432 | 5,374 | 4,297 | 7,514 | 6,549 | Upgrade
|
Net Income Growth | 36.22% | 44.05% | -42.81% | 14.73% | -27.30% | Upgrade
|
Shares Outstanding (Basic) | 3,594 | 3,594 | 3,594 | 3,594 | 3,594 | Upgrade
|
Shares Outstanding (Diluted) | 3,594 | 3,594 | 3,594 | 3,594 | 3,594 | Upgrade
|
EPS (Basic) | 2.07 | 1.50 | 1.20 | 2.09 | 1.82 | Upgrade
|
EPS (Diluted) | 2.07 | 1.49 | 1.20 | 2.09 | 1.82 | Upgrade
|
EPS Growth | 38.33% | 25.05% | -42.81% | 14.74% | -25.85% | Upgrade
|
Free Cash Flow | 116,238 | 104,657 | 88,737 | 94,552 | 110,817 | Upgrade
|
Free Cash Flow Per Share | 32.34 | 29.12 | 24.69 | 26.31 | 30.83 | Upgrade
|
Dividend Per Share | 0.350 | 0.300 | 0.260 | 0.460 | 0.400 | Upgrade
|
Dividend Growth | 16.67% | 15.38% | -43.48% | 15.00% | 33.33% | Upgrade
|
Operating Margin | 20.96% | 14.79% | 9.31% | 3.93% | 6.43% | Upgrade
|
Profit Margin | 6.14% | 4.78% | 3.97% | 2.38% | 2.42% | Upgrade
|
Free Cash Flow Margin | 96.06% | 93.15% | 82.01% | 29.91% | 40.87% | Upgrade
|
EBITDA | 27,610 | 18,940 | 12,444 | 14,760 | 19,290 | Upgrade
|
EBITDA Margin | 22.82% | 16.86% | 11.50% | 4.67% | 7.11% | Upgrade
|
D&A For EBITDA | 2,246 | 2,326 | 2,367 | 2,346 | 1,857 | Upgrade
|
EBIT | 25,365 | 16,614 | 10,078 | 12,413 | 17,433 | Upgrade
|
EBIT Margin | 20.96% | 14.79% | 9.31% | 3.93% | 6.43% | Upgrade
|
Effective Tax Rate | 42.16% | 11.85% | - | - | 21.17% | Upgrade
|
Revenue as Reported | - | - | - | 315,858 | 270,113 | Upgrade
|
Updated Sep 23, 2024. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.